A Phase II Study of Plerixafor (AMD3100) plus G-CSF for Autologous Hematopoietic Progenitor Cell Mobilization in Patients with Hodgkin Lymphoma

Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial

Norbert Schmitz, Beate Pfistner, M. Sextro et al. · The Lancet · 2002 · 1.1K citations

Cell Therapy, Transplantation, Marrow Transplantation +10

Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist

Hal E. Broxmeyer, Christie M. Orschell, D. Wade Clapp et al. · The Journal of Experimental Medicine · 2005 · 1.1K citations · Full text

Cell Therapy, Immunology, Rapid Mobilization +19

Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial

David C. Linch, A. H. Goldstone, Annabel McMillan et al. · The Lancet · 1993 · 1K citations

Transplantation, Marrow Transplantation, Stem Cell Transplantation +9

Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist

W. Conrad Liles, Hal E. Broxmeyer, Elin Rodger et al. · Blood · 2003 · 715 citations

Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma

Rainer Haas, Robert Möhle, S. Frühauf et al. · Blood · 1994 · 471 citations · Full text